This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2009-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Machida, JP (2011)
- Tokyo, JP (2009 - 2015)
Company Filing History:
Years Active: 2009-2015
Title: Masayo Suzuki: Innovator in Antibody Development
Introduction
Masayo Suzuki is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to her name, her work is paving the way for advancements in medical treatments and diagnostics.
Latest Patents
One of her latest patents involves DNA encoding an anti-system ASC amino acid transporter 2 (ASCT2) antibody. This invention aims to provide a monoclonal antibody that is useful for treating or diagnosing diseases related to the ASCT2 transporter. The patent details a monoclonal antibody that specifically recognizes the native three-dimensional structure of the extracellular region of ASCT2. It also includes a hybridoma that produces the antibody, a DNA encoding the antibody, and a vector containing the DNA. Furthermore, it outlines a process for producing the antibody or its fragments, along with therapeutic and diagnostic agents utilizing these antibodies.
Career Highlights
Masayo Suzuki is currently associated with Kyowa Hakko Kirin Co., Limited, where she continues her innovative work in antibody research. Her expertise in this area has led to significant advancements in understanding and treating diseases related to amino acid transporters.
Collaborations
Throughout her career, Masayo has collaborated with notable colleagues, including Hiroshi Ando and Norihiko Shiraishi. These collaborations have further enhanced her research and contributed to the success of her inventions.
Conclusion
Masayo Suzuki's contributions to the field of biotechnology, particularly in the development of monoclonal antibodies, highlight her role as a leading inventor. Her innovative work continues to impact medical science and improve treatment options for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile